Acute Ischemic Stroke
Unmet Clinical Need
IN THE NEWS
Unit 6, Galway Business Park, Dangan
NEXT GENERATION STROKE TECHNOLOGY
Perfuze is developing innovative medical technology for clot removal in stroke patients
Scroll to Explore
(1) World Stroke Organisation www.world-stroke.org
(2) Mozaffarian et al. Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association.
ABOUT ISCHEMIC STROKE
Stroke is the second leading cause of death and is the leading cause of adult disability.
Over 13 million people worldwide will have a stroke this year and more than 5 million people will die as a result.
(3) Nogueira et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct.
N. Engl. J. Med.
(4) Goyal et al. Endovascular Thrombectomy after Large-Vessel Ischaemic Stroke: A Meta-Analysis of Individual Patient Data from Five Randomised Trials.
UNMET CLINICAL NEED
Despite recent clinical advances in stroke therapy, less than 50% of stroke patients treated today achieve a positive clinical outcome.
Video Button Icon
Watch Full Video
Perfuze was founded in 2018 by Wayne Allen and Liam Mullins and are located in Galway City in the West of Ireland.